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Abstract
Incomplete intestinal absorption of fructose might lead to abdominal complaints such as pain, flatulence and diarrhoea.
Whether defect fructose transporters such as GLUT5 or GLUT2 are involved in the pathogenesis of fructose malabsorption
is a matter of debate. The hydrogen production by colonic bacteria is used for diagnosis with the hydrogen breath test.
However, the appropriate fructose test dose for correct diagnosis is unclear. Subjects with fructose malabsorption show
increased breath hydrogen levels and abdominal symptoms after fructose administration but do not report any
symptoms when fructose is given together with glucose. This beneficial effect of glucose, however, cannot be explained
yet but might be used for clinical care of these subjects.
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Background
The complex process of sugar digestion and absorption
can be disturbed due to defect digestion enzymes or
monosaccharide transporters. Lactose malabsorption is
caused by variants in the promoter region of the LCT gene
coding for lactase-phlorizin hydrolase. Consequently, the
cleavage of lactose in its components glucose and galact-
ose is impaired [1]. In patients with glucose-galactose
malabsorption, mutations in the SLC5A1 coding region
result in truncated or mistargeted glucose-galactose trans-
porter SGLT1. Due to impaired absorption of glucose and
galactose, newborns develop life-threatening diarrhoea
and dehydration [2]. The molecular and the genetic causes
of fructose malabsorption are unknown. Like other sugar
malabsorptions, the disease is characterized by colicky
abdominal pain, flatulence and diarrhoea. These symp-
toms are caused by bacterial fermentation of unabsorbed
fructose in the colon resulting in production of hydrogen,
carbon dioxide, methane and short-chain fatty acids.
Moreover, the increased sugar load in the colon might
cause osmotic diarrhoea (Fig. 1). Patients should avoid
fructose-rich food such as apples, pears and red peppers.
Nutrition anamnesis is often not helpful for making diag-
nosis since affected subjects instinctively avoid fructose-
rich foods. For therapy, the beneficial effect of glucose on
fructose absorption is used. Patients tolerate fruits such as
bananas or grapefruits which contain fructose and glucose
in at least equimolar concentrations. Apples are not toler-
ated because of their high fructose (7 g/apple) and lower
glucose (2.3 g/apple) content (ratio 3:1). Furthermore, the
simultaneous intake of glucose can avoid symptoms after
fructose consumption.
Are sugar transporter defects responsible for fructose
malabsorption?
Since GLUT5 represents the main intestinal fructose trans-
porter, its involvement in the pathophysiology of fructose
malabsorption seems obvious. Glut5 knock-out mice dem-
onstrated decreased fructose uptake in the jejunum and
reduced plasma fructose levels compared to their litter-
mates. However, intestinal fructose transport is not com-
pletely abolished indicating the presence of other intestinal
fructose transporters. The feeding of a diet containing 60 %
fructose for 14 days resulted in increased GLUT5 expres-
sion in mice [3]. Whether fructose absorption can be
enhanced by increased GLUT5 expression due to fructose-
rich diet in humans is not investigated so far.
The GLUT5 coding region was analyzed using SSCP (sin-
gle-strand conformational polymorphism) in 8 children
with fructose malabsorption, 6 healthy controls and 13
healthy parents of patients [4]. The patients were diagnosed
by hydrogen breath testing with 1 g/kg fructose and occur-
rence of symptoms during the test. No GLUT5 variant was
found that correlated with the occurrence of fructose
malabsorption. Nevertheless, an involvement of GLUT5 in
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the pathophysiology of fructose malabsorption cannot be
excluded since this cohort was quite small, the age of
patients was very young (ranging from 8 months to 5 years,
median 2.75 years) and half of the patients showed positive
sucrose breath test questioning the diagnosis of isolated
fructose malabsorption [4]. Moreover, SSCP analysis has a
low sensitivity compared to DNA sequencing, and non-
coding regions were not investigated in this study.
Other fructose transporters such as GLUT2 or SGLT4
are also present in the small intestine and might play a
pathogenic role in this condition (Fig. 2) [5–7]. GLUT2















Fig. 1 Symptom generation in fructose malabsorption. As consequence of impaired absorption, fructose reaches the colon and is metabolized by colonic
bacteria. The products hydrogen, carbon dioxide, methane and short-chain fatty acids (SCFA) and the osmotic water influx cause the typical symptoms.
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Fig. 2 Intestinal sugar transport. Fructose is transported into the enterocyte by GLUT5 and glucose and galactose by SGLT1. Exit of fructose,
glucose and galactose is provided by GLUT2. The presence and relevance of GLUT2 and SGLT4 in the apical membrane and GLUT5 in the
basolateral membrane are under debate. Verified transport routes are illustrated in dark grey, hypothetical in light grey
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presence in the apical membrane is questionable [8, 9].
If GLUT2 is responsible for the exit of fructose only, an
important role for fructose malabsorption is unlikely.
GLUT2 mutations are associated to Fanconi-Bickel syn-
drome, an autosomal recessive inherited disorder char-
acterized by hepatorenal glycogen accumulation, renal
tubular dysfunction and glucose/galactose intolerance.
However, no disturbed fructose absorption has been
reported in this disease [10].
The hypothesis that intestinal GLUT5 or GLUT2 expres-
sion is reduced in fructose malabsorption was tested by
Wilder-Smith et al. in 11 adults with fructose malabsorp-
tion (positive breath test after ingestion of 35 g fructose in
combination with abdominal symptoms) and 15 control
subjects. The messenger RNA (mRNA) content and protein
expression of GLUT5 and GLUT2 was similar in both
groups [11].
Unlike GLUT5 and GLUT2, SGLT4 provides Na
+-dependent secondary active transport of glucose and
possibly fructose. Fructose transport by SGLT4 was not
directly shown but an inhibition of glucose uptake by fruc-
tose was demonstrated. So far, the expression of SGLT4 in
the apical membrane and its role for intestinal fructose
absorption has not been investigated [6].
Is the hydrogen breath test appropriate for diagnosis?
Fructose malabsorption is usually diagnosed by hydro-
gen breath test (HBT). Since the absorption capacity for
fructose is limited in healthy people also, the appropriate
fructose dose for this test is under discussion. After
ingestion of 50 g fructose, 58 % of 102 subjects demon-
strated incomplete absorption with a rise in breath
hydrogen over the arbitrarily defined threshold level of
20 ppm. In these subjects, 25 % reported abdominal
symptoms during the test period. Twenty-one persons
with a positive breath test after ingestion of 50 g fructose
repeated the procedure with 25 g fructose. With this
lower dose, only 11 % showed incomplete absorption.
Moreover, of the 11 % who had abdominal symptoms,
only one person showed an elevated breath hydrogen
level [12]. Rao and co-workers conducted a double-blind
study with 20 healthy subjects: all subjects exhibited
negative HBT with 15 g fructose. Two subjects (10 %)
showed incomplete absorption with a dose of 25 g fruc-
tose but did not report symptoms. After administration
of 50 g fructose, 80 % of subjects showed breath hydro-
gen rise over baseline and 55 % demonstrated abdominal
symptoms [13]. When 31 children received 2 g fructose
per kg bodyweight (max. 50 g), 71 % showed positive
breath test and 13 % had abdominal symptoms [14]. As
shown by these and other studies, a dose of 50 g (corre-
sponds to approximately seven medium-sized apples) in
adults or 2 g/kg in children exceeds in the majority the
intestinal absorption capacity whereas the administration
of ≤25 g fructose in adults or ≤1 g/kg in children is
thought to be appropriate for diagnosis of fructose
malabsorption. Until the reason for fructose malabsorp-
tion is unclear, it is hardly possible to define the right
dose for HBT and to discriminate between normal and
abnormal. Therefore, it is difficult to estimate the preva-
lence in the general population. A detailed review about
hydrogen breath testing in fructose malabsorption was
published by Jones et al. [15].
Age dependence of fructose absorption
There is evidence that the prevalence of fructose malab-
sorption correlates with the age. After administration of
1 g/kg fructose, 16 out of 23 children aged 1–3 years
showed elevated peak hydrogen excretion, whereas only 7
out of 26 older children (4–6 years) demonstrated
increased breath hydrogen levels. Furthermore, peak
hydrogen was higher in the younger age group [16]. A
clear correlation between age and HBT (0.5 g/kg, max.
10 g fructose) was found in a study population of 1093
children and adults, where fructose absorption capacity
was rising up to the age of 10 years. From the age of 10 to
79, no differences were observed regarding absorption
capacity [17]. On the contrary, the prevalence of lactose
intolerance is low in infants and rises with the age. In
pediatric populations from Finland and Somalia, the lac-
tase activity decreased mainly between 5 and 10 years of
age [18].
The beneficial effect of glucose
The simultaneous ingestion of glucose can improve fruc-
tose absorption and prevent symptoms. In 1984, it was
described that children showed increased breath hydrogen
excretion after administration of 2 g/kg (max. 50 g) fructose
but not after ingestion of fructose together with equimolar
amounts of glucose or galactose. Only the three children
with the highest breath hydrogen peaks demonstrated
abdominal symptoms [14]. This effect was confirmed by
Rumessen et al. in 10 healthy adults. An elevated breath
hydrogen excretion after ingestion of 50 g fructose was
observed in 7 out of 10 people. In contrast, breath hydro-
gen peaks were normal after simultaneous ingestion of
equimolar amounts glucose [19]. Patients with fructose
malabsorption can additionally consume glucose if they
want to eat fructose-rich food to avoid symptoms. The
reason for this absorption enhancing effect is under discus-
sion. Fructose could be passively absorbed due to glucose-
stimulated water absorption. The observation that this
beneficial effect was not only mediated by sugars but also
by amino acids such as alanine supports this hypothesis
[20]. However, fructose transport was not enhanced after
ingestion of fructose and urate in equal amounts [14].
Another explanation is the presence of a glucose dependent
fructose co-transport system [19]. An involvement of the
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fructose and glucose transporter GLUT2 has been pro-
posed because trafficking of GLUT2 to the apical mem-
brane after glucose load was observed in rats [8]. In
contrast, no evidence for GLUT2 presence in the apical
brush-border membrane in response to glucose was shown
by Röder et al. indicating the involvement of other trans-
porters [9]. In a cohort of six healthy subjects, it was ob-
served that glucose and galactose can prolongate gastric
emptying [21]. Possibly, the delayed arrival of fructose in
the small intestine due to delayed gastric emptying could
explain the increased fructose absorption by simultaneous
glucose administration. Moreover, an enhancing effect of
glucose and lipids on sorbitol absorption was demonstrated
which might be explained by similar mechanisms [22].
Fructose malabsorption as cause for recurrent abdominal
pain
Gijsbers et al. conducted a double-blinded placebo-
controlled (DBPC) trial in children with recurrent abdom-
inal pain. First, 121 children performed a HBT with 2 g/kg
fructose (max. 50 g). From those children who were posi-
tive (65 %), 49 were set on a fructose elimination diet.
Sixty-five percent of them reported absence of symptoms
during the diet but only 13 out of 31 children (41 %)
responded to an open provocation with fructose. Finally, all
8 children which demonstrated symptoms after provoca-
tion, showed no symptoms after double-blinded placebo-
controlled re-provocation. In summary, none of the chil-
dren demonstrated positive hydrogen breath test together
with the absence of symptoms during elimination and
symptoms during the DBPC trial. An explanation why the
children showed positive hydrogen breath test after
fructose ingestion but no symptoms during DBPC with
fructose could be the different dose. During the breath
test, a maximum of 50 g fructose (2 g/kg) was given
whereas in the DBPC trial, 25 g was consumed over the
whole day. However, factors such as the gut microbiota,
transit time and diet composition might also cause varying
fructose tolerance [23]. As mentioned above, 2 g/kg fruc-
tose cannot be completely absorbed in the majority of
children. Therefore, the dose is too high to discriminate
between fructose absorption and malabsorption. Since the
elimination and provocation was conducted at home, it is
possible that children did not strictly follow the elimin-
ation and provocation guidelines leading to inconsistent
results. Nevertheless, fructose malabsorption was most
likely not the prominent factor for abdominal pain in this
cohort.
Dietary fructose restriction in IBS
High-fructose consumption can trigger symptoms in
patients with irritable bowel syndrome (IBS). With a dose
of 25 g fructose, 22 % (20/90) of IBS patients showed posi-
tive hydrogen breath test. Amongst fructose malabsorbers,
35 % had abdominal symptoms during the test whereas
26 % of the fructose absorbers demonstrated symptoms
[24]. With the same fructose dose, 10 % (2/20) of healthy
adults demonstrated elevated breath hydrogen without
any symptoms [13]. Fructose intake is restricted within
the low FODMAP (fermentable oligo-, di- and monosac-
charides and polyols) diet often recommended for IBS
patients. In a cohort of 90 IBS patients, symptoms im-
proved during this diet. Moreover, the occurrence of fruc-
tose malabsorption was associated with improvement of
symptoms [25]. A further study in 67 IBS patients showed
symptom amelioration after standard IBS diet and low
FODMAP diet without significant differences between the
two diets [26]. However, potential undesirable side-effects
of long-term restricted diets should be taken into account.
Conclusion
The pathophysiology of fructose malabsorption remains
unclear. If there are genetic or epigenetic variations in
intestinal fructose transporters such as GLUT5, GLUT2 or
SGLT4 needs to be elucidated. Genetic variants within the
GLUT5 coding regions are unlikely but not excluded as
reason for impaired fructose absorption. There are first
hints that GLUT5 and GLUT2 expression is not lower in
affected subjects. Probably, there are different mechanisms
leading to this condition. To elucidate the underlying
mechanism, genetic analysis in well-defined cases and
controls should be performed either by candidate gene
approach or complete genome sequencing. Because the
absorption capacity for fructose is highly individual, it is
difficult to determine the right dose for HBT. There is
agreement that 50 g fructose in adults or 2 g/kg fructose
in children exceed the absorption capacity of the majority.
A dose of ≤25 g in adults or ≤1 g/kg in children seems to
be appropriate. The variance of breath test results at
different times of the day and the reproducibility should
be assessed. It remains unclear why increased gas produc-
tion in the intestine during HBT does not necessarily
cause abdominal symptoms. Possible, the intestinal sensi-
tivity and pain perception is highly individual. Whether
fructose malabsorption is more common in IBS patients
needs to be verified. However, restriction of fructose and
other fermentable saccharides can be helpful in therapy.
To clarify the absorption enhancing effect of glucose, it is
important to understand the mechanisms of intestinal
sugar transport and to gain insights into possible interac-
tions of sugar transporters. To address this question, fu-
ture studies should verify the assumption that different
amino acids also promote fructose absorption.
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